Normal view MARC view ISBD view

Measuring Toxicity in Phase I Clinical Trials--Letter.

Hyman, David M

Measuring Toxicity in Phase I Clinical Trials--Letter. [electronic resource] - Clinical cancer research : an official journal of the American Association for Cancer Research Apr 2016 - 1828 p. digital

Publication Type: Letter; Comment

ISSN: 1557-3265

Standard No.: 10.1158/1078-0432.CCR-15-3043 doi

Subjects--Topical Terms:
Antineoplastic Agents--therapeutic use
Clinical Trials, Phase I as Topic
Clinical Trials, Phase II as Topic
Humans
Maximum Tolerated Dose
Neoplasms--drug therapy

Print
Cite
Add to your cart (remove)
Save record
BIBTEX Dublin Core MARCXML MARC (non-Unicode/MARC-8) MARC (Unicode/UTF-8) MARC (Unicode/UTF-8, Standard) MODS (XML) RIS ISBD
More searches

Search for this title in:
Other Libraries (WorldCat) Other Databases (Google Scholar) Online Stores (Bookfinder.com) Open Library (openlibrary.org)